Factor Bioscience to Unveil iMacrophages Engineered to Combat Solid Tumors at the ISSCR Annual Meeting

-Presentations will include the latest preclinical data from Factor's engineered iMacrophage program (FACT-112) -Factor to reveal latest advances in RNA-based gene editing and directed differentiation platforms CAMBRIDGE, Mass., June 10, 2025 /PRNewswire/ -- Factor Bioscience Inc., a...

Read More